Bioventus Reschedules Reporting of Fourth Quarter Fiscal Year 2022 Financial Results to March 31, 2023

Rhea-AI Summary

Bioventus (BVS) has announced a change in the release schedule of its fourth quarter fiscal year 2022 financial results, now set for March 31, 2023, before market opening. The adjustment allows for additional time to finalize financial statements. Following the announcement, Bioventus will hold a conference call at 8:30 a.m. Eastern Time on the same day to discuss the results and provide updates on business operations. Interested participants can join via telephone or listen through a live webcast on the Investor Relations section of the Bioventus website, which will also host an archived version of the call for replay until March 30, 2024.

Positive

• Change in reporting date allows for thorough completion of financial statements, potentially leading to improved accuracy.

Negative

• Delay in financial results release may create uncertainty among investors.

DURHAM, N.C., March 29, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will now report financial results for the fourth quarter of fiscal year 2022 before the market opens on Friday, March 31, 2023, rather than as previously announced to allow additional time to complete its financial statements. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.

To participate in the conference call, dial 1-833-636-0497 (domestic) or +1-412-902-4241 (international) and refer to the Bioventus, Inc. Conference Call.

A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company's website at https://ir.bioventus.com/. The webcast will be archived at the same site and available for replay until March 30, 2024.

About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Investor and Media Inquiries:
Dave Crawford
919-474-6787
Dave.Crawford@bioventus.com  

FAQ

When will Bioventus release its fourth quarter fiscal year 2022 financial results?

Bioventus will release its fourth quarter fiscal year 2022 financial results on March 31, 2023, before market opening.

What time is the Bioventus conference call to discuss financial results?

The conference call to discuss Bioventus' financial results will be held at 8:30 a.m. Eastern Time on March 31, 2023.

How can I listen to Bioventus' financial results conference call?

You can participate in the conference call by dialing 1-833-636-0497 domestically or +1-412-902-4241 internationally, or you can listen via a live webcast on the Bioventus Investor Relations website.

Will the Bioventus conference call be available for replay?

Yes, the conference call will be archived and available for replay on the Bioventus Investor Relations website until March 30, 2024.